Vanguard Group Inc Sensei Biotherapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 618,757 shares of SNSE stock, worth $278,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
618,757
Previous 618,757
-0.0%
Holding current value
$278,440
Previous $383,000
3.13%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SNSE
# of Institutions
22Shares Held
2.23MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX650KShares$292,5000.07% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny216KShares$97,0070.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$77,7750.0% of portfolio
-
Geode Capital Management, LLC Boston, MA163KShares$73,4120.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA90.4KShares$40,6920.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $13.8M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...